Cargando…
Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
BACKGROUND: Despite regulatory restrictions, off-label marketing of pharmaceutical products has been common in the US. However, the scope of off-label marketing remains poorly characterized. We developed a typology for the strategies and practices that constitute off-label marketing. METHODS AND FIN...
Autores principales: | Kesselheim, Aaron S., Mello, Michelle M., Studdert, David M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071370/ https://www.ncbi.nlm.nih.gov/pubmed/21483716 http://dx.doi.org/10.1371/journal.pmed.1000431 |
Ejemplares similares
-
The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine
por: Wang, Bo, et al.
Publicado: (2017) -
Kenny’s Whistleblowing and Stanger’s Whistleblowers
por: Vandekerckhove, Wim
Publicado: (2020) -
Conflict of Interest Reporting by Authors Involved in Promotion of Off-Label Drug Use: An Analysis of Journal Disclosures
por: Kesselheim, Aaron S., et al.
Publicado: (2012) -
The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
por: Sinha, Michael S., et al.
Publicado: (2018) -
Whistleblowers: Incentives, Disincentives, and Protection Strategies
por: Lipman, Frederick
Publicado: (2011)